Growth funding Strong funding history including a $99.5M raise across multiple rounds signals aggressiveness in product expansion and potential for bigger enterprise deals, partnerships, and international scaling opportunities.

FDA cleared FDA-cleared non-hormonal birth control app positions Natural Cycles as a trusted health tech solution, creating a credible entry point for co-sell partnerships with healthcare providers, clinics, and wellness platforms.

Expansion momentum Recent launches such as NC° Perimenopause and the wristband for thermometry indicate a diversified product roadmap and cross-sell opportunities to engage users across different life stages.

Tech stack Cloud-first architecture (Google Cloud, Firebase, GKE) and data-driven teams (Medical, Algorithm, Data) imply potential for B2B collaborations around data analytics, telemetry, and API integrations.

Market positioning Strong focus on women’s health with a global footprint (Stockholm base, Nordic expansion) and a multi-product approach create opportunities with health systems, insurers, and digital health distributors looking to offer trusted fertility and menopause solutions.